Targeted Gene Editing in Porcine Spermatogonia.

CRISPR/Cas9 gene targeting homology directed repair homology-mediated end joining pig spermatogonia

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2020
Historique:
received: 09 11 2020
accepted: 31 12 2020
entrez: 15 2 2021
pubmed: 16 2 2021
medline: 16 2 2021
Statut: epublish

Résumé

To study the pathophysiology of human diseases, develop innovative treatments, and refine approaches for regenerative medicine require appropriate preclinical models. Pigs share physiologic and anatomic characteristics with humans and are genetically more similar to humans than are mice. Genetically modified pigs are essential where rodent models do not mimic the human disease phenotype. The male germline stem cell or spermatogonial stem cell (SSC) is unique; it is the only cell type in an adult male that divides and contributes genes to future generations, making it an ideal target for genetic modification. Here we report that CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing in porcine spermatogonia that include SSCs is significantly more efficient than previously reported editing with TALENs and allows precise gene editing by homology directed repair (HDR). We also established homology-mediated end joining (HMEJ) as a second approach to targeted gene editing to enable introduction of larger transgenes and/or humanizing parts of the pig genome for disease modeling or regenerative medicine. In summary, the approaches established in the current study result in efficient targeted genome editing in porcine germ cells for precise replication of human disease alleles.

Identifiants

pubmed: 33584819
doi: 10.3389/fgene.2020.627673
pmc: PMC7876475
doi:

Types de publication

Journal Article

Langues

eng

Pagination

627673

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD091068
Pays : United States
Organisme : NIH HHS
ID : R01 OD016575
Pays : United States
Organisme : NIGMS NIH HHS
ID : R43 GM108150
Pays : United States
Organisme : NIGMS NIH HHS
ID : R44 GM108150
Pays : United States

Informations de copyright

Copyright © 2021 Webster, Bondareva, Solin, Goldsmith, Su, Lara, Carlson and Dobrinski.

Déclaration de conflit d'intérêts

DW, SS, TG, DC, and ID are employees and/or shareholders in Recombinetics, Inc., a company that commercializes gene editing in livestock. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Reproduction. 2006 Oct;132(4):617-24
pubmed: 17008473
J Cell Physiol. 2009 Aug;220(2):460-8
pubmed: 19388011
Sci Rep. 2015 Sep 18;5:14253
pubmed: 26381350
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25677-25687
pubmed: 31754036
Bioinformatics. 2015 Dec 15;31(24):4014-6
pubmed: 26358729
FASEB J. 2008 Feb;22(2):374-82
pubmed: 17873102
Reproduction. 2001 Mar;121(3):347-54
pubmed: 11226060
J Anim Sci Biotechnol. 2020 Apr 10;11:33
pubmed: 32308978
Commun Biol. 2018 Oct 2;1:158
pubmed: 30302402
Stem Cell Reports. 2015 Jul 14;5(1):75-82
pubmed: 26095606
Cell Res. 2015 Jan;25(1):67-79
pubmed: 25475058
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11303-7
pubmed: 7972054
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11298-302
pubmed: 7972053
Diabetes. 2013 May;62(5):1505-11
pubmed: 23274907
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17382-7
pubmed: 23027955
J Surg Res. 2018 Sep;229:28-40
pubmed: 29937002
Methods Mol Biol. 2010;649:247-56
pubmed: 20680839
Diabetologia. 2017 Aug;60(8):1541-1549
pubmed: 28480495
Adv Genet. 2012;80:37-97
pubmed: 23084873
Stem Cells Dev. 2017 Aug 1;26(15):1121-1131
pubmed: 28474535
Reproduction. 2017 Sep;154(3):181-195
pubmed: 28576919
Biol Reprod. 2002 Jan;66(1):21-8
pubmed: 11751259
Stem Cells. 2006 Apr;24(4):805-14
pubmed: 16282443
Bioinformatics. 2014 May 15;30(10):1473-5
pubmed: 24463181
Biol Reprod. 2013 Jan 31;88(1):27
pubmed: 23221397
Elife. 2020 May 15;9:
pubmed: 32412410
Mol Reprod Dev. 2008 Feb;75(2):250-64
pubmed: 17595009
Cell Rep. 2015 Mar 24;10(11):1828-35
pubmed: 25772367
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14931-6
pubmed: 12391306
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16526-31
pubmed: 24014591
J Androl. 2005 Nov-Dec;26(6):698-705
pubmed: 16291964
Reprod Fertil Dev. 2009;21(1):60-6
pubmed: 19152746
Biol Reprod. 2001 Jul;65(1):23-30
pubmed: 11420219
Biol Reprod. 2002 Jul;67(1):55-63
pubmed: 12079999
DNA Repair (Amst). 2018 Oct;70:55-66
pubmed: 30179733
Mol Reprod Dev. 2018 Mar;85(3):250-261
pubmed: 29393557
J Vis Exp. 2019 Oct 3;(152):
pubmed: 31633676
Science. 2008 Sep 26;321(5897):1837-41
pubmed: 18818360
Mol Reprod Dev. 2012 Apr;79(4):255-61
pubmed: 22231935
Biol Reprod. 2002 Sep;67(3):874-9
pubmed: 12193397
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24195-24204
pubmed: 32929012
Theriogenology. 2006 Dec;66(9):2091-103
pubmed: 16870245
Anim Reprod. 2015 Jan-Mar;12(1):93-104
pubmed: 27390591

Auteurs

Dennis Webster (D)

Recombinetics, Inc., St. Paul, MN, United States.

Alla Bondareva (A)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Staci Solin (S)

Recombinetics, Inc., St. Paul, MN, United States.

Taylor Goldsmith (T)

Recombinetics, Inc., St. Paul, MN, United States.

Lin Su (L)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Nathalia de Lima E Martins Lara (NLEM)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Daniel F Carlson (DF)

Recombinetics, Inc., St. Paul, MN, United States.

Ina Dobrinski (I)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Classifications MeSH